Activity
-
I look forward to this event to talk about our work on iPSC-derived NK cells. It should be a great meeting, and the location is the absolute best.
I look forward to this event to talk about our work on iPSC-derived NK cells. It should be a great meeting, and the location is the absolute best.
Liked by Michelle Duquette, PhD
-
It has been an exciting year thus far introducing Bracco’s technology to the cell therapy world - and we’re barely at the end of Q1! I’m thankful…
It has been an exciting year thus far introducing Bracco’s technology to the cell therapy world - and we’re barely at the end of Q1! I’m thankful…
Liked by Michelle Duquette, PhD
-
Excited to join this conversation on April 22 alongside an incredible group of leaders. CAR-T has come a long way, but the harder questions around…
Excited to join this conversation on April 22 alongside an incredible group of leaders. CAR-T has come a long way, but the harder questions around…
Shared by Michelle Duquette, PhD
Experience & Education
More activity by Michelle
-
A few themes emerging this morning at Hope is Not a Workflow: Resilience isn’t just a characteristic of the therapy. It has to be built into the…
A few themes emerging this morning at Hope is Not a Workflow: Resilience isn’t just a characteristic of the therapy. It has to be built into the…
Liked by Michelle Duquette, PhD
-
As a scientist and a mother navigating neurological injury… I’ve learned one hard truth: 👉 Access is everything. There are therapies being…
As a scientist and a mother navigating neurological injury… I’ve learned one hard truth: 👉 Access is everything. There are therapies being…
Liked by Michelle Duquette, PhD
-
I am excited to announce the second Cell Therapy and #CMC #Manufacturing Forum on April 30th, 2026 @ 8am to 1.30pm PT organized by the California…
I am excited to announce the second Cell Therapy and #CMC #Manufacturing Forum on April 30th, 2026 @ 8am to 1.30pm PT organized by the California…
Liked by Michelle Duquette, PhD
-
Trenchant Bio, the CGT manufacturing platform developer for gene-modified cells, and Invetech have announced that they have entered into a strategic…
Trenchant Bio, the CGT manufacturing platform developer for gene-modified cells, and Invetech have announced that they have entered into a strategic…
Liked by Michelle Duquette, PhD
-
Women In Bio-San Diego hosted “AI & Rare Disease – A New Era in Diagnosis and Care,” bringing together scientists, clinicians, entrepreneurs, patient…
Women In Bio-San Diego hosted “AI & Rare Disease – A New Era in Diagnosis and Care,” bringing together scientists, clinicians, entrepreneurs, patient…
Liked by Michelle Duquette, PhD
Other similar profiles
Explore top content on LinkedIn
Find curated posts and insights for relevant topics all in one place.
View top content